Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇ ▇▇▇▇▇▇ [Address] If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 3 contracts
Sources: Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.), Change of Control Agreement (Poniard Pharmaceuticals, Inc.), Separation/Consulting Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇▇ ▇. ▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ [Address] ▇▇▇▇▇ ▇▇, ▇▇ ▇▇▇▇▇ If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 2 contracts
Sources: Change of Control Agreement (Poniard Pharmaceuticals, Inc.), Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ [Address] ▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 2 contracts
Sources: Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.), Change of Control Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇ ▇▇▇▇▇▇ [Address] If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 2 contracts
Sources: Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.), Change of Control Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇ ▇. ▇▇▇ ▇▇▇▇-▇▇▇▇ ▇▇▇▇▇▇ [Address] ▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 2 contracts
Sources: Change of Control Agreement (Poniard Pharmaceuticals, Inc.), Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇ ▇▇▇▇ ▇▇ ▇▇▇▇▇▇ [Address] ▇▇▇ #▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 2 contracts
Sources: Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.), Change of Control Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ [Address] If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer Corporate Secretary With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 2 contracts
Sources: Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.), Change of Control Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ [Address] If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 2 contracts
Sources: Change of Control Agreement (Poniard Pharmaceuticals, Inc.), Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ [Address] If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 2 contracts
Sources: Change of Control Agreement (Poniard Pharmaceuticals, Inc.), Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇▇ [Address] ▇▇▇▇▇ If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 2 contracts
Sources: Change of Control Agreement (Poniard Pharmaceuticals, Inc.), Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇ ▇▇▇▇ ▇▇ ▇▇▇▇▇▇ [Address] ▇▇▇ #▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 2 contracts
Sources: Change of Control Agreement (Poniard Pharmaceuticals, Inc.), Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ [Address] San Francisco, CA 94123 If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 2 contracts
Sources: Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.), Change of Control Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ [Address] San Francisco, CA 94121 If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington WA 98119 Attn: Chief Executive Officer Corporate Secretary With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ Attn: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ Except as set forth in Section 7.4 hereof, if notice is mailed, such notice shall be effective upon mailing.
Appears in 1 contract
Sources: Change of Control Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ [Address] ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ If to the Company: Poniard Pharmaceuticals, Inc. NeoRx Corporation ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer Corporate Secretary With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 1 contract
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ [Address] ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer Corporate Secretary With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 1 contract
Sources: Key Executive Severance Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇ ▇▇▇▇▇▇ [Address] If to the Company: Poniard Pharmaceuticals, Inc. ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 Seattle, Washington 98119 Attn: Chief Executive Officer With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 1 contract
Sources: Change of Control Agreement (Poniard Pharmaceuticals, Inc.)
Form of Notice. Every notice required by the terms of this Agreement shall be given in writing by serving the same upon the party to whom it was addressed personally or by registered or certified mail, return receipt requested, at the address set forth below or at such other address as may hereafter be designated by notice given in compliance with the terms hereof: If to the Executive: ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ [Address] ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ If to the Company: Poniard Pharmaceuticals, Inc. NeoRx Corporation ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ West, Suite 500 West Seattle, Washington 98119 Attn: Chief Executive Officer Corporate Secretary With a copy to: ▇▇▇▇▇▇▇ Coie LLP ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 1 contract